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ScienceDirectEnzymes shape cellular metabolism, are regulated, fast, and for
most cases specific. Enzymes do not however prevent the
parallel occurrence of non-enzymatic reactions. Non-
enzymatic reactions were important for the evolution of
metabolic pathways, but are retained as part of the modern
metabolic network. They divide into unspecific chemical
reactivity and specific reactions that occur either exclusively
non-enzymatically as part of the metabolic network, or in
parallel to existing enzyme functions. Non-enzymatic reactions
resemble catalytic mechanisms as found in all major enzyme
classes and occur spontaneously, small molecule (e.g. metal-)
catalyzed or light-induced. The frequent occurrence of non-
enzymatic reactions impacts on stability and metabolic
network structure, and has thus to be considered in the context
of metabolic disease, network modeling, biotechnology and
drug design.
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Introduction
The metabolic network originates from a low number (or
one) of ancestral forms, and all living organisms share core
reaction sequences and structural properties in their meta-
bolic networks [1]. Glycolysis and gluconeogenesis, pen-
tose phosphate pathway (PPP) and tricarboxylic acid
(TCA) cycle are central metabolic pathways and exemplary
for the conservation of metabolism [2,3]. Their products
glucose, pyruvate, ribose-5-phosphate and erythrose-4-
phosphate are common precursors for amino acids, lipids
and nucleotides. Despite the high level of conservation of3 These authors contributed equally to this work.
www.sciencedirect.com the reactions, the participating enzymes have however
multiple origins. Sequences of glycolytic enzymes differ
between Archaea and Bacteria/Eukaryotes [2,4,5]. This
divergence can be explained by both, independent evolu-
tionary origins of enzymes and stepwise replacement of
ancestral enzymes by modern forms [5]. Both scenarios
require an initial reaction sequence as ‘template’, as evo-
lution can only select for a functional product (‘end-prod-
uct problem’ [6]). The initial metabolic pathway can thus
either evolve backward from the advantageous end-prod-
uct (retro-evolution), provided that precursors are formed
non-enzymatically [6], or by improving a non-enzymatic
reaction sequence starting from its most rate-limiting step
[7]. A plausible primordial base can be traced for glycolysis
and the PPP, as several of their reactions can be replicated
with metal catalysts, in particular Fe(II), under conditions
reproducing the ocean chemistry of the Archean world [8].
Fe(II) was broadly available before oxygenation of the
early Earth [9], implying a scenario for the first glycolytic
enzymes being simple iron-binding RNA or oligopeptide
molecules, which would have possessed the potential of
enhancing many reactions now found in central metabo-
lism [7,8] (Box 1).
Three classes of non-enzymatic reactions
contribute to modern cellular metabolism
It is important to emphasize that the same thermodynamic
principles apply for non-enzymatic and enzymatic reac-
tions, and every enzymatic reaction can occur in principle
also non-enzymatically [10]. Non-enzymatic reactivity of
metabolites is a well-known phenomenon since the begin-
ning of enzymology (Figure 1a). However, network topol-
ogies or genome-scale metabolic models were not
prevailing research questions until the event of Systems
Biology, and until recently for many cases the metabolic
role of non-enzymatic reactions obtained little attention.
The presence of enzymes does not prevent non-enzymatic
reactions to occur across the metabolic landscape. On the
basis of their principal mode of action, we divide non-
enzymatic reactions into three classes (Figure 1b): Class I
reactions present broad chemical reactivity and low speci-
ficity. These include Maillard-reactions, a conjugation of
amino group-containing compounds (e.g. amino acids) and
sugars [11], oxidation reactions driven by reactive oxygen
species (ROS) and non-enzymatic covalent modifications
of lipids and proteins (alkylation, glycosylation and acety-
lation) [12]. These indiscriminate reactions are not the
main focus of this review; nonetheless, they have a strongCurrent Opinion in Biotechnology 2015, 34:153–161
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Box 1 Evolutionary replacement of metal catalysis with protein
catalysts: the case of ribulose 5-phosphate 3-epimerase, which
exists as an Fe(II)-dependent form and an iron-independent form.
While in many bacteria the Fe(II)-dependent form dominates, in
higher eukaryotes it is the iron independent form [69]. As the
isomerization of ribulose 5-phosphate is catalyzed by Fe(II) also in
the absence of the enzyme [8] indicates that the iron-dependent
form is the older enzyme. Exchanging the Fe(II)-dependent with the
metal-independent form of the epimerase does provide selective
advantage: the Fe(II) catalyst in the bacterial epimerase gets readily
oxidized, in fact this enzyme is the first one damaged when
Escherichia coli is exposed to oxidants; the Fe(II) dependence of
RPE is thus one major cause why E. coli cells can tolerate only
moderate H2O2 levels [70].effect on cellular physiology and are important driving
forces for evolution.
Other non-enzymatic reactions are highly specific and are
integral part of the metabolic network. Class II reactions
occur purely non-enzymatically. A well-known example is
the maturation of vitamin D3 where a precursor is trans-
ported to the skin, to be converted by UV light to pre-
vitamin D3 [13
]. Most Class II reactions are spontaneous
reactions which do not depend on a catalyst or an atypicalFigure 1
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vitamin D3 biosynthesis, in which previtamin D3 under-
goes spontaneous isomerization forming vitamin D3 [13
].
Class III non-enzymatic reactions occur parallel to en-
zyme functions. Class III reactions are widespread in
metabolism, and indicate that many metabolic pathways
descend from promiscuous or non-enzymatic precursors.
Frequently, the parallel enzyme operates to prevent
unwanted secondary products that would be generated
in the non-enzymatic reaction (negative catalysis). Exam-
ples include the spontaneous transamination of glyoxylic
acid and amino acids [14], the isomerization of propyl
residues [15], the decarboxylation of aminomalonic acid
[16] and the formation of oxysterols from cholesterol [17].
Class III non-enzymatic reactions occur analogous to all
six major enzymatic classes, illustrated for the following
examples:
(i) Oxidoreductases: catalase (Figures 2 and 3a). Hydro-
gen peroxide (H2O2) is formed as a (by-)product in
various redox reactions. In combination with Fenton
chemistry, H2O2 can react into superoxide and
damage proteins, RNA, DNA and lipids [18].Enzymatic catalysis
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(triosephosphate isomerase [53]) and 2G36 (iron–sulfur cluster containing tryptophanyl-tRNA synthetase [39]).Catalase degrades H2O2 into water and oxygen [19].
A similar reaction is also catalyzed by metals,
inorganic salts and organic compounds [20,21].
Despite catalase is faster than the non-enzymatic
reactions, the non-enzymatic catalysts are present at
much higher cellular concentrations (iron: mM–mM
range versus catalase that is present in the nanomolar
range (i.e. 38 nM) ; [22,23]), and thus relevant for
total reactivity.
(ii) Transferases: glutathione-S-transferases (GST)
(Figures 2 and 3b). GSTs comprise a large family
of enzymes that transfer substrates to glutathione
(GSH) for cellular detoxification. Several substrates
(i.e. 4-hydroxynonenal, isothiocyanates or catecho-
lamines) conjugate to GST also non-enzymatically
[24–26]. The reactive GSH thiol-group provides the
redox potential for both the enzymatic and non-
enzymatic conjugation [26].
(iii) Hydrolases: 6-Phosphogluconolactonase (6PGL)
(Figures 2 and 3c). 6PGL is an enzyme of the
oxidative PPP that provides NADPH and pentose
metabolites [27]. Spontaneous hydrolysis of 6-
phosphogluconolactone into 6-phosphogluconate
occurs at rates that would allow a considerablewww.sciencedirect.com PPP flux [28]. The presence of 6PGL additionally
accelerates flux, but predominantly prevents the
formation of undesired side-products produced
when 6-phosphogluconolactone reacts with amino
acids, lipids, polyamines or alcohols [28]. Also other
lactonases such as aldonolactonase (L-ascorbate
biosynthesis) [29] and hydrolase-type reactions such
as acyl phosphatases [28], epoxide hydrolases [30]
and lipoxygenase (colneleic acid degradation) [31]
possess analogous non-enzymatic reactions.
(iv) Lyases: ergothioneine and tetrahydrobiopterin (BH4)
(Figures 2 and 3d). Ergothioneine is a metabolite
produced by bacteria and fungi, and actively taken
up by mammalian cells [32]. Its biosynthesis involves
a threefold methylation of the alpha-amino group of
histidine, followed by cysteinylation of the histidine
side chain [33]. The final reaction is catalyzed by a
pyridoxal phosphate-dependent lyase, or occurs in a
non-enzymatic manner ([33], supporting informa-
tion). Another example for a non-enzymatic lyase
reaction is found in the BH4 salvage pathway that
regenerates BH4 with the help of dihydropterin-4a-
carbinolamine dehydratase and dihydropteridine
reductase (DHPR). When DHPR activity becomesCurrent Opinion in Biotechnology 2015, 34:153–161
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rearranges non-enzymatically allowing salvage of
BH4 [34].
(v) Isomerases: glycolysis, PPP and isomerization in
vitamin D biosynthesis (Figures 2 and 3e). Non-
enzymatic isomerization reactions are frequently
observed, for instance between glycolytic inter-
mediates fructose-6-phosphate, glucose-6-phos-
phate or mannose-6-phosphate [35] as well as PPP
metabolites ribulose-5-phosphate, xylulose-5-phos-
phate and ribose-5-phosphate [8]. Another example
is the isomerization of glyceraldehyde-3-phosphate
and dihydroxyacetone phosphate. Here, the enzyme
triosephosphate isomerase (TPI) speeds up the
reaction and prevents the formation of toxic
methylglyoxal [36]. In some instances UV light
provides the activation energy. Bacteria use UV-
induced trans/cis isomerizations in Class I rhodop-
sins as a source of energy [37], mammalian cells
exploit photo-induced trans/cis isomerizations in the
eye pigment retinal [38]. As previously mentioned,
non-enzymatic isomerizations are also required in
the maturation of vitamin D [13].
(vi) Ligases: tRNA loading and hydrolysis (Figures 2 and
3f). The process of tRNA-amino acid ligation, tRNA
loading, is enzymatically attributed to aminoacyl
tRNA synthetases and crucial for ribosome function
and protein biosynthesis [39]. tRNAs also ligate (and
hydrolyse) non-enzymatically, a reaction best stud-
ied for tryptophan-tRNA ligase [40,41]. Of note,
non-enzymatic ligation reactions have lower sub-
strate specificity and can cause tRNA mischarging
[42].
The success of enzymes in replacing non-
enzymatic reactions
Small-molecule compounds are excellent catalysts in
order to accelerate chemical reactions. However, in bio-
logical systems other important constraints apply in par-
allel, and explain the success of enzymes (Figure 4):
(i) Limited catalyst availability: metal ions and minerals
may qualify as excellent catalysts, but often are not
readily available. Molybdenum for instance is low
concentrated in most ecosystems, while Fe(II)
became limited during earth history [9]. Enzymatic
catalysts render metabolism less dependent on the
presence of rare and/or insoluble molecules [8].(Figure 3 Legend) Examples for biologically important non-enzymatic chemic
peroxide molecules into water and oxygen is catalyzed non-enzymatically or b
electrophiles allowing the formation of glutathione-S-conjugates, either non-en
is hydrolyzed to 6-phosphogluconate in the PPP spontaneously, or through 6-
prevent unwanted side-reactions. (d) The final step in ergothioneine biosynthe
pyridoxal phosphate-dependent lyase, or non-enzymatically by pyridoxal phos
biosynthesis are non-enzymatic isomerizations, one UV-light dependent and o
(Class II reactions). (f) Tryptophan-tRNA ligase or a non-enzymatic reaction co
www.sciencedirect.com (ii) Substrate specificity: enzyme folds can achieve substan-
tial substrate specificity and differentiate similar
molecules, for instance glucose-6-phosphate from
fructose-6-phosphate [43]. This allows specificity and
chemical compartmentalization: analogous reactions
can occur in parallel when relying on structurally
distinguishable co-factors such as NADP(H) and
NAD(H) [44].
(iii) Negative catalysis: enzymes can function to prevent
side reactions, a concept termed negative catalysis
[45]. Negative catalysts are essential for the efficiency
of metabolism and of particular medical importance,
as mutations within these enzymes are causative for a
number of inherited metabolic diseases. Examples
include mutations of isocitrate dehydrogenase (IDH)
that lead to an increased release of the side product D-
2-hydroxyglutarate in cancer (IDH1 and IDH2), or in
D-2-hydroglutaric aciduria (IDH2) [46,47], and TPI
where pathogenic mutations have been associated
with the production of methylglyoxal [36].
(iv) Regulation of metabolism: surviving starvation and
stress situations as well as development of multicel-
lular organisms requires regulation of metabolism.
Non-enzymatic catalysts are however not readily
tunable. Enzymes instead allow multiple levels of
control, including allosteric regulation, cooperativity,
post-translational modifications and genetic/tran-
scriptional regulation [48,49].
When enzymatic catalysts have their limits
The dominance of enzymes impressively demonstrates
their benefits for living organisms. Nonetheless, also en-
zymatic catalysis creates limitations. First, enzymatic struc-
tures can be highly temperature sensitive, a reason for the
low thermo-tolerance of most species. Secondly, enzymatic
catalysis is costly, as protein biosynthesis is one of the most
energy-consuming cellular processes [50]. Third, enzymes
are prone to chemical modifications, and need constant
replacement, a cause of ageing and cancer [51]. Less
intuitively, a forth constraint arises from their high speci-
ficity: structurally similar molecules can bind to catalytic
pockets without being metabolized; turning harmless
molecules into metabolic inhibitors. An example for the
latter is TPI. In vitro regarded as a perfect enzyme solely
limited by diffusion rate [52], it is in vivo competitively
inhibited by molecules with high structural similarity to its
substrates, as for example phosphoenol pyruvate (PEP)
[53]. Some enzymes evolved structural features to limital reactions. (a) The intermolecular redox reaction of two hydrogen
y catalase (EC 1.11.1.6). (b) The thiol group of GSH is an acceptor of
zymatically or through GSTs (EC 2.5.1.18). (c) 6-phosphogluconolactone
phosphogluconolactonase (EC 3.1.1.31), whose main function is to
sis is the decomposition of hercynylcysteine sulfoxide either by a
phate alone. (e) The two final steps in cholecalciferol (vitamin D3)
ne spontaneous. For both reactions no enzymatic counterpart is known
njugate tryptophan to its tRNA.
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The success of enzymatic catalysis in cellular metabolism. The conversion of a substrate into its product can be mediated by non-enzymatic
catalysts (organic/metal, left panel) or enzymatically (right panel). Non-enzymatic catalysts accelerate reactions but often display a broad substrate
and product spectrum. While this variability is exploited during evolution, metabolism gains efficiency with enzymes that are specific and are less
dependent on availability of rare catalysts. Moreover enzymes allow to more precisely regulate certain reactions and therewith to distribute flux
through-out the metabolic network.such problems, for instance fatty aldehyde dehydrogenase
possesses a gatekeeper helix that prevents nonspecific
metabolites from diffusing into its catalytic center [54].
Non-enzymatic reactions as a challenge for
genome-scale metabolic modeling
Metabolic modeling has become popular in biotechnolo-
gy, for instance helping to understand function and be-
havior of metabolic systems in constraint-based flux
balance analyses (FBA) [55]. Limited experimental evi-
dence is a restraining factor when constructing models for
most species. Metabolic networks are therefore assem-
bled on the basis of sequence homology [56]. A few
changed residues can however alter substrate specificity
of enzymes [57], and metabolic reconstruction using
comparative genomics further fails to capture non-enzy-
matic reactions [58]. The global problem is less obvious in
frequently studied model organisms, since for many non-
enzymatic reactions an enzymatic counterpart exists
(Class III). However, with increasing phylogenetic dis-
tance the predictive power of comparative genomics
decreases. This problem appears most relevant in ther-
mophilic microorganisms [2], as it is an intrinsic property
of non-enzymatic reactions to occur faster with increasing
temperatures. Thus, in a Class III reaction the enzymatic
contribution to the total rate becomes less important with
temperature. For instance, non-enzymatic, metal-cata-
lyzed PPP reactions strongly accelerate at temperatures
above 60 8C [8]. The absence of a PPP enzyme in a
thermophile is thus not necessarily an indicator of wheth-
er this pathway is present or not.
Also unspecific Class I reactions have a strong influence
on the metabolic network, especially when cells are
exposed to increased temperature and stress conditions.
Exploring their system wide impact is — due to theirCurrent Opinion in Biotechnology 2015, 34:153–161 unspecific nature and the formation of various non-enzy-
matic metabolic products — a difficult task. Class I reac-
tions require sophisticated metabolite repair strategies
[59], that can represent evolutionary branching points for
novel metabolic pathways.
In this respect, it is worth mentioning the possible non-
enzymatic contribution to metabolic transport processes.
Non-enzymatic transport is often referred to as ‘mem-
brane leakage’, a term which however falls short of taking
into account that specific physical properties of metabo-
lite and membrane composition determine the probabili-
ty of a molecule to membrane diffuse. Metabolites can be
attracted to specific physico-chemical environments
resulting in their accumulation, causing spontaneous spa-
tial segregation, hydrophilic–lipophilic phase separation,
and membrane adsorption [60]. A well understood case is
the phase separation of polar and apolar metabolites, a
process of potential relevance for intracellular metabo-
lism. Another aspect is the possible free diffusion across
membranes, which is often triggered by external factors
such as heat, pH or oxidative stressors [61]. Indeed, the
evolution towards the modern, tightly hydrophobic lipid
composition of membranes may have only been facilitat-
ed upon the appearance of membrane protein channels,
transporters and pumps [62]. Membranes were likely
more permeable in early organisms, which thus could
more likely exploit non-enzymatic chemistry in mem-
brane transport and separation processes [63].
Non-enzymatic metabolic reactions and drug
design
Metabolism offers a plethora of targets for developing
the next generation of pharmaceuticals to treat cancer
and neurodegenerative disorders [64,65]. Nonetheless,
no ‘cancer-specific’ or ‘Alzheimer-specific’ metabolicwww.sciencedirect.com
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operate in narrow, intelligently designed therapeutic
windows. The presence of non-enzymatic reactions puts
an additional constraint on the selection of drug targets.
Class I/II non-enzymatic reactions are largely not target-
able, as they are a consequence of the chemical properties
of the metabolites. Interesting cases are the Class III
reactions, as the non-enzymatic reaction is not affected by
targeting of the parallel enzyme. At best, this would
simply limit the efficiency of the drug. Many Class III
enzymes are however negative catalysts. Their inhibition
increases the production of unwanted by-products. This
can cause problematic side effects, but may create a
possibility to overflow cells with toxic metabolites to
target for example cancer cells or bacterial pathogens.
Concluding remarks
Non-enzymatic reactions occur frequently within the
metabolic network. We distinguish reactions with low
substrate specificity (Class I) from specific reactions that
occur exclusively non-enzymatically (Class II), and reac-
tions that occur analogous to the six principal enzyme
categories (Class III). Providing a template for the evolu-
tionary selection of metabolic enzymes, non-enzymatic
reactions did form the basis for the evolution of metabo-
lism. They have however never been depleted from the
chemical environment of the cell, and occur within or in
parallel to exiting enzyme function. Non-enzymatic reac-
tions should thus not be regarded as cumbersome side
effects, but as integral part of the metabolic network. As
such, they play a role in human metabolic disease, and
have to be considered in genome-scale reconstructions of
metabolic networks, in particular in extremophiles, when
designing biotechnological models, and further, when
selecting enzymes for drug targeting and considering
the side-effects of drugs. Non-enzymatic reactions are
thus central for understanding fundamental problems in
biology and play an essential role in cellular metabolism,
human health, and ageing.
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